samedan logo
 
 
spacer
home > ebr > summer 2002 > effective gene transfer in neurobiology
PUBLICATIONS
European BioPharmaceutical Review

Effective Gene Transfer in Neurobiology

The potential of gene therapy is now being realised, with therapeutic success in single gene inherited immunodeficiency disorders, and positive clinical progress in a number of other fields including cancer. Gene therapy is also showing great potential in the treatment of nerve injuries and neurodegenerative disorders, as solutions to some major challenges are found. The most fundamental challenge has been to achieve safe and efficient delivery of genes into the right cells in vivo. This article reviews the vectors available for gene therapy in neurobiological applications and examines potential gene therapy approaches for neurodegenerative disease and nerve regeneration.


Read full article >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Professor Alan Kingsman, Chief Executive Officer and Co-Founder of Oxford BioMedica plc, is an internationally-recognised authority on gene expression and retrovirus research and has over 20 years' experience in this field.
spacer
Professor Alan Kingsman
spacer
spacer
Print this page
Send to a friend
Privacy statement

Industry Events

FT Global Pharmaceutical and Biotechnology Conference 2008

2-3 December 2008, The Cumberland, London

FT Global Pharmaceutical and Biotechnology Conference is Europe’s pre-eminent industry event attended by leading executives, government decision makers, investors, analysts and other specialist providers. It provides a unique platform to present new perspectives,’ feel the pulse’ of the industry, and network with peers across the sector.
More info >>

 
News and Press Releases

Lilly Selects ICON to Manage its Clinical Data Management Business Outside the US

18th November 2008
More info >>

 

©2000-2007 Samedan Ltd.
About Us | Register | Login | Site Map | Terms and Conditions | Contact Us |
Add to favourites

Print this page

Send to a friend
Privacy statement